Christin E Burd, PhD
College of Arts & Sciences
Molecular Carcinogenesis and Chemoprevention
>Cancer ● Melanoma ● DNA Damage ● Lymphoma, Primary Effusion ● Body Mass Index
Christin Burd, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where she focuses her research on improving our understanding of the connections between cancer and aging.Her team’s goal is to bridge bench science and clinical trials. In particular, she aims to improve methods to prevent, diagnose and treat melanoma. Recent work from her lab examines how aging of the immune system is impacted by different cancer therapies and may influence drug toxicity and patient outcomes. Dr. Burd has developed several state-of-the-art genetically engineered models which allow scientists to track the formation and progression of spontaneous cancers and test melanoma prevention strategies. She was the first in Ohio to receive a prestigious Damon Runyon-Rachleff Innovation Award. This award funds Dr. Burd’s ongoing research to develop new models and methods to combat tumors with a RAS gene mutation. Dr. Burd’s work is featured in numerous well-respected journals, including Cell, Nature Medicine, Cancer Discovery, Pigment Cell & Melanoma Research and Molecular Cancer Research.